Applied BioMath, LLC to Present at PEGS Summit
News provided by
Share this article
CONCORD, Mass., May 4, 2021 /PRNewswire/ -- Applied BioMath (
www.appliedbiomath.com), the industry-leader in applying systems pharmacology and mechanistic modeling, simulation, and analysis to de-risk drug research and development today announced their participation at the PEGS Summit occurring virtually May 11-13, 2021.
John Burke, PhD, Co-founder, President and CEO of Applied BioMath will present "Applied BioMath Assess™ - An Early Feasibility Assessment Tool for Biotherapeutics" within the conference program, Advancing Bispecific Antibodies and Combination Therapy to the Clinic on Tuesday, May 11th at 10:40 a.m. ET. In this presentation, Dr. Burke will demonstrate how Applied BioMath's new and interactive software tool systematically investigates the therapeutic characteristics (e.g., format, half-life, affinity, mechanism of action) given target characteristics (e.g., target expression and turnover) necessary to achieve success criteria given the predetermined target profile (e.g., dose, administration, frequency) to help accelerate and de-risk discovery projects.